Good News, Bad News
Studies show pharma has succeeded at raising disease awareness. Brand loyalty, though, has suffered.
Lifestyle Decision
Recent drug trials, and marketing efforts in Europe, for Acomplia indicate that Sanofi-Aventis may be seeking a life-threatening indication for its much-hyped weight-loss drug.
